Written answers
Tuesday, 29 January 2019
Department of Health
Medicinal Products Reimbursement
Denis Naughten (Roscommon-Galway, Independent)
Link to this: Individually | In context | Oireachtas source
441. To ask the Minister for Health the reason pioglitazone remains an approved drug under the GMS for the treatment of diabetes in view of the fact that the US Food and Drug Administration has found it to be associated with bladder tumours; and if he will make a statement on the matter. [4367/19]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
No comments